Skip to content
中文产业新闻评分30Chinese source

瑞普泊肽肥胖合并PMOS Ⅱ期临床结果在EASD 2026以Late-Breaking Short Oral形式发布

恒瑞代谢遇见EASD（二）｜瑞普泊肽针对肥胖合并PMOS Ⅱ期临床研究结果重磅公布

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.